Microbial Testing Service Market Size to Surge $14.04 Bn by 2034

Microbial Testing Service Market Size, Segments and Regional Growth Analysis

The global microbial testing service market was estimated at US$ 5.36 billion in 2023 and is projected to grow to US$ 14.04 billion by 2034, rising at a compound annual growth rate (CAGR) of 9.15% from 2024 to 2034. The demand for microbial testing services is increasing due to increasing research and development in testing new drugs and therapeutics, essentially due to the growing antibiotic resistance among pathogens.

Unlock Infinite Advantages: Subscribe to Annual Membership

Market Overview

Microbial testing services are procedures conducted to detect the presence of microbes and the identification of the type of microorganism in different settings such as hospitals, pharmaceuticals, and biotechnology. The microbial testing service market is growing significantly due to prevalence of infectious diseases. Apart from this, the services are needed to ensure patient safety to avoid any health risks. Organization and healthcare service providers follow strict regulatory guidelines to ensure patient safety.

Microbial Testing Service Market Trends

In September 2023, the women's health startup Evvy announced that it has finished its $14 million Series A fundraising round, which it plans to utilize to expand its platform for vaginal health testing and care.

The table lists the name of the microbiome start-ups and the funding they got till 2024. The growth of these companies is directly going to promote the growth of the microbial testing service market because these companies are going to conduct microbial testing on daily basis.

Growing Pharmaceutical Industry Needs Microbial Testing

The pharmaceutical industry is growing significantly due to the growing prevalence of infectious diseases, chronic conditions, and geriatric population. The microbial testing service market will grow in the future with the growth of the pharmaceutical industry. Microbial testing is conducted to ensure the safety of patients during the development of therapeutic drugs, vaccines, kits, and reagents. Microbial testing is also done during the production of biologics, post-sterilization, and after packaging. Microbial testing is mandatory in order to maintain the Good Manufacturing Practices (GMP) proposed by WHO.

High-Cost Restraints the Microbial Testing Service Market

The growth of the market is limited up to some extent by the high cost of microbial testing services. The cost is of testing is high due to the use of equipment with advanced technology and demand for skilled staff. Without these two requirements, the chances of human errors increase, leading to false results. With technological advancements and the integration of AI & machine learning, the equipment is getting more advanced and expensive. Training sessions are also needed to train the professionals to use the advanced equipment, which further increases the cost of the services.

Regional Insights

Strong Presence of Pharma & Biotech Companies Drive North America

North America dominated the microbial testing service market share by 45% in 2023. One of the major factors contributing to the market’s growth in the region is the presence of pharmaceutical and biotechnology companies. These companies use microbial testing services during development & testing of therapeutics drugs, making of vaccines, development and analysis of genetically modified microorganisms, testing of new treatment procedure, and so on.

The U.S. held the largest share of the microbial testing service market in 2023. The country has advanced healthcare, pharmaceutical, and biotechnology sectors. There are organization like FDA that promote the growth of the market in the U.S. by providing guidelines, and investments for innovation and research. There is a strong presence of organizations that use microbial testing for maintaining GMPs.

Growing Prevalence of Disease Drive Asia Pacific’s Market

Asia Pacific is expected to grow at the fastest rate during the forecast period. The microbial testing service market is growing rapidly in the region due to the growing prevalence of infectious diseases. The region has the largest population which further increases the number of patients. Countries like China, India, South Korea, and Japan are the major contributors for the market’s growth. India and China have the largest population which increases the demand for therapeutics and drugs. China has the second-largest and India has the third-largest pharmaceutical industry worldwide.

Apart from this, the governments are also taking initiates to improve the healthcare industry. These initiatives include investments, awareness program, support to start-ups, healthcare programs in remote areas, production of vaccines and medicines for exporting, and programs for free vaccines. All these initiatives use microbial testing to maintain GMPs.

For instance,

• In September 2024, Alopex, Inc. and Bharat Biotech established a partnership for the co-development and marketing of Alopexx's exclusive broad-spectrum antimicrobial vaccine, AV0328, in India and other low- and lower-middle-income nations.

Segmental Insights

By product, the instruments segment dominated the microbial testing service market in 2023. Microbial service instruments include microscopes, slides, incubators, centrifuge, autoclaves, pH meter, colony counter, Bunsen burner and so on. These instruments are automated, semi-automated or manual. Each instrument is needed for conducting proper microbial service.

By test type, the bacterial segment held the major share of the market in 2023. The segment is dominant because bacterial testing is conducted in hospitals, pharmaceutical industries, biotechnology industries, and diagnostics labs to ensure that products, and surfaces are free of bacteria. Its is essential for ensuring patient safety. Apart from this the growing prevalence of infectious diseases caused by bacteria promote the segment’s growth.

By application, the gastrointestinal diseases segment dominated the microbial testing service market in 2023. Worldwide, digestive illnesses are quite common, can be deadly, and cause a great deal of suffering. A significant portion of health care cost and consumption is attributed to digestive illnesses (1,2). The productivity and quality of life of patients are also impacted by several of these illnesses (3). Over 40 million people in the US suffer from digestive disorders, which also result in millions of clinical visits each year and $119.6 billion in medical expenses.

By end-user, the hospitals segment held the largest share of the microbial testing service market in 2023. In hospitals microbial testing is conducted after sterilization of broths and mediums for growing culture, for diagnosis microbial disease/infection, for developing proper treatment option, for avoiding development of hospital-based infections, and during pandemics.

Recent Developments

• In February 2024, in order to establish a catalytic grant fund for organizations engaged in pathogen genome monitoring, the World Health Organization (WHO) announced that contributors have contributed US$4 million.
• In August 2023, Viome Life Sciences, an at-home diagnostics business, will introduce its gut microbiome testing kit at 200 CVS pharmacies after securing $86.5 million in an oversubscribed series C fundraising round.

Top Companies in the Microbial Testing Service Market

• BioMerieux,
• BD
• Thermo Fisher Scientific
• Merck
• Charles River Laboratories
• SGS
• Intertek
• Agilent Technologies
• Bureau Veritas
• Bio-Rad Laboratories
• TÜV SÜD
• CTI
• Eurofins Scientific
• Neogen, Qiagen
• Guangdong Huankai Microbial
• Autobio Diagnostics
• Zhejiang Tailin Bioengineering

Segments Covered in the Report

By Product

• Instruments
• Reagent

By Test Type

• Bacterial
• Viral
• Fungal

By Application

• Gastrointestinal Diseases
• Respiratory Diseases
• Bloodstream Infection
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases
• Others

By End User

• Hospitals
• Diagnostic Centers
• Academic and Research Institutes
• Others

By Region

• North America
  • U.S.
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait